Tirzepatide
This product is in research for the following:
Tirzepatide is a once-weekly injectable medication that activates both GIP and GLP-1 receptors. It is prescribed for adults to improve blood sugar in type 2 diabetes, for chronic weight management, and to treat obstructive sleep apnea. It promotes significant weight loss and appetite reduction alongside diet and exercise.
Brand Names & Indications
Tirzepatide is sold under two different brand names, depending on its prescribed use:
Mounjaro: Approved for improving blood sugar (glucose) in adults with type 2 diabetes mellitus, alongside diet and exercise.
Zepbound: Approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) who also have at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol).
How It Works
Tirzepatide is a first-in-class dual agonist. It functions by mimicking two natural gut hormones:
GIP (Glucose-dependent insulinotropic polypeptide): Helps reduce food intake and regulates energy balance.
GLP-1 (Glucagon-like peptide-1): Stimulates insulin secretion, slows stomach emptying, and signals the brain that you are full, which helps reduce hunger and "food noise".
All products exceed 99% purity from our sourced vendor's. All Products are for Research Only and Not For Human Consumption. Products are tested in the US by Freedom Diagnostics a USA based company.